"The FDA has requested additional data supporting the efficacy of Probuphine, including:
The ability of Probuphine to provide opioid blockade of relevant doses of agonists
The effect of higher doses of Probuphine, ideally doses more closely approximating the blood plasma levels associated with sublingual doses of buprenorphine of 12 to 16 mg / day"
How do you get the data requested by the FDA without additional trials?
Try: it's an OVERPRICED penny stock because of a PUMP & DUMP operation on it's way back home to PennyLand.
and a mass exodus for the doors.
INO is a penny stock.
back down to where it started, or lower.
How much is that worth? .04 cents per 240,000,000 shares?
The 34 year string of failed trials continues.
INO is still in a downtrend.
Sub $1 is coming again.